Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) and Biotricity (OTCMKTS:BTCY – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.
Analyst Recommendations
This is a breakdown of recent ratings for Strata Skin Sciences and Biotricity, as reported by MarketBeat.
Get Strata Skin Sciences alerts:
Strata Skin Sciences currently has a consensus target price of $6.00, suggesting a potential upside of 287.10%. Given Strata Skin Sciences’ stronger consensus rating and higher probable upside, equities analysts clearly believe Strata Skin Sciences is more favorable than Biotricity.
Earnings & Valuation
This table compares Strata Skin Sciences and Biotricity”s top-line revenue, earnings per share and valuation.
Biotricity has lower revenue, but higher earnings than Strata Skin Sciences. Biotricity is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Strata Skin Sciences and Biotricity’s net margins, return on equity and return on assets.
Insider and Institutional Ownership
32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 39.0% of Strata Skin Sciences shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
Strata Skin Sciences has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.
Summary
Strata Skin Sciences beats Biotricity on 9 of the 14 factors compared between the two stocks.
About Strata Skin Sciences
(Get Free Report)
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
About Biotricity
(Get Free Report)
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.